July 12, 2018

Insulet Extends Partnership with Glooko in Europe to Optimise Diabetes Data Management

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management...

Read More

June 22, 2018

Glooko Releases New Version of Mobile App, Presents Usability Outcomes from Mobile Insulin Dosing System (MIDS) Study

Glooko, the leader in diabetes data management, today announced participation in the 78th Annual American Diabetes Association (ADA) meeting taking place...

Read More

June 18, 2018

DreaMed Diabetes Granted FDA Authorization to Market Advisor Pro, Offering Personalized Optimization of Insulin Pump Therapy

DreaMed Diabetes, developer of personalized diabetes management solutions, announced today that the U.S Food and Drug Administration (FDA) has granted...

Read More

June 11, 2018

Glooko Introduces New Web Analytics Platform That Includes the Most Powerful Capabilities from Diasend

Glooko, the leader in diabetes data management, today announced the delivery of a new version of the Glooko Web Application (Population Tracker) that includes...

Read More

June 10, 2018

Senseonics & Glooko Announce Partnership on Integrated Diabetes Management

(NYSE-American: SENS), a medical technology company focused on the development and commercialization of transformative glucose monitoring products, today...

Read More

May 15, 2018

Glooko Study Highlights Insights Into How Diabetes Healthcare Professionals Use Continuous Glucose Monitoring (CGM) Data

Glooko, the leader in diabetes data management, today announced the results of its recent study which  examined diabetes healthcare professionals’ use...

Read More